Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity

by Zitvogel, Laurence , Lu, Min , Pan, Zhizhong , Fu, Lingyi , Kang, Boxi , Martin, Vincent , Lin, Xia , He, Jingjing , Ma, Yuting , Chen, Jinfeng , Shi, Minxin , Kroemer, Guido , Yu, Kuai , Morand, Eric , Li, Qingqing , Chen, Jian , Zhang, Zeming , Zhou, Penghui , Leader, Andrew , Zhang, Shuqing , Lanfumey, Laurence , Lin, Shangqing , Krzysiek, Roman , Schlecht-Louf, Géraldine , Yang, Heng , Yang, Jie , Calmette, Joseph

in Animal models / Anticancer properties / Anxiety / Cancer / Carcinogens / Cell activation / Clonal deletion / Corticosterone / Cortisol / Dendritic cells / Glucocorticoids / Immunity / Immunosurveillance / Interferon / Leukocytes / Lymphocytes / Lymphocytes T / Mood / Social interactions / Supplements / Therapy / Tumors / γ-Interferon

2019

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity

2019

Confirm

Do you wish to request the book?

Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity

2019

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity

Zitvogel, Laurence,

Lu, Min,

Pan, Zhizhong,

Fu, Lingyi,

Kang, Boxi,

Martin, Vincent,

Lin, Xia,

He, Jingjing,

Ma, Yuting,

Chen, Jinfeng,

Shi, Minxin,

Kroemer, Guido,

Yu, Kuai,

Morand, Eric,

Li, Qingqing,

Chen, Jian,

Zhang, Zeming,

Zhou, Penghui,

Leader, Andrew,

Zhang, Shuqing,

Lanfumey, Laurence,

Lin, Shangqing,

Krzysiek, Roman,

Schlecht-Louf, Géraldine,

Yang, Heng,

Yang, Jie,

Calmette, Joseph

2019

Overview

Psychological distress has long been suspected to influence cancer incidence and mortality. It remains largely unknown whether and how stress affects the efficacy of anticancer therapies. We observed that social defeat caused anxiety-like behaviors in mice and dampened therapeutic responses against carcinogen-induced neoplasias and transplantable tumors. Stress elevated plasma corticosterone and upregulated the expression of glucocorticoid-inducible factor Tsc22d3, which blocked type I interferon (IFN) responses in dendritic cell (DC) and IFN-γ+ T cell activation. Similarly, close correlations were discovered among plasma cortisol levels, TSC22D3 expression in circulating leukocytes and negative mood in patients with cancer. In murine models, exogenous glucocorticoid injection, or enforced expression of Tsc22d3 in DC was sufficient to abolish therapeutic control of tumors. Administration of a glucocorticoid receptor antagonist or DC-specific Tsc22d3 deletion reversed the negative impact of stress or glucocorticoid supplementation on therapeutic outcomes. Altogether, these results indicate that stress-induced glucocorticoid surge and Tsc22d3 upregulation can subvert therapy-induced anticancer immunosurveillance.

Share this book

Add to My Shelf

Publisher

Nature Publishing Group

Subject

Animal models

/ Anticancer properties

/ Anxiety

/ Cancer

/ Carcinogens

/ Cell activation

/ Clonal deletion